Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry
Supporters
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Georg Semmler
IMPACT OF HEPATIC AND SYSTEMIC INFLAMMATION ON THE DYNAMIC COMPONENT OF PORTAL HYPERTENSION DURING DISEASE REGRESSION IN ALCOHOL-RELATED CIRRHOSIS
Georg Semmler
et al.
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
Georg Semmler
et al.
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
Georg Semmler
et al.
THE IMPACT OF TRANSMEMBRANE 6 SUPERFAMILY 2 (TM6SF2) RS58542926 ON LIVER-RELATED EVENTS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Georg Semmler
et al.
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
Georg Semmler
et al.
SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Georg Semmler
et al.
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
Georg Semmler
et al.
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
Georg Semmler
et al.
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
Georg Semmler
et al.
THE ALPHA-1 ANTITRYPSIN PI*Z ALLELE INDEPENDENTLY PREDICTS LIVER TRANSPLANTATION/DEATH IN ACLD PATIENTS
Georg Semmler
et al.
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Georg Semmler
et al.
CLINICAL SIGNIFICANCE OF SUBSTANTIALLY ELEVATED VON WILLEBRAND FACTOR ANTIGEN LEVELS IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
Georg Semmler
et al.
Item 21 - 32 / 32
1
2
Chat with us
, powered by
LiveChat